PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Int J Antimicrob Agents. Author manuscript; available in PMC 2012 February 1.
Published in final edited form as:
PMCID: PMC3032353
NIHMSID: NIHMS249498

Use of functional interactions with MarA to discover chromosomal genes affecting antibiotic susceptibility in Escherichia coli

Sir,

Antibiotic action and cell responses to antibiotics are very complex and include not only the direct target of an antibiotic but also secondary targets, signalling effects and indirect effects such as antibiotic-induced generation of hydroxyl radicals or changes in gene expression and cell metabolism. Identifying genes important for antibiotic action in the cell or antibiotic resistance would uncover new targets for potentiating existing antibiotics or for discovering new ones. Several approaches have been used to identify these genes, including studying antibiotic-resistant strains of clinical origin or selected in the laboratory and, more recently, screening the entire Keio collection of 4000 single-gene knockouts of Escherichia coli for increased antibiotic susceptibility [1]. Such approaches have been successful but have limitations.

Here we propose a new approach to identify genes affecting antibiotic resistance or susceptibility based on screening genes that have functional interactions with other genes already known to be important for drug resistance. Such an approach was suggested by recent studies [2] with the multiple antibiotic resistance regulator MarA, a transcription factor in E. coli that upregulates multidrug efflux and downregulates membrane permeability [2]. The effect of inactivation of 24 unrelated chromosomal genes using the EZ-Tn5™ <Kan-2> transposome (Epicentre, Madison, WI) on antibiotic resistance mediated by MarA was studied [2]. Fifteen of these genes affected MarA-mediated antibiotic resistance, whereas nine of them did not. Here we examine whether these 24 inactivated genes affect antibiotic susceptibility per se in the absence of MarA.

Antibiotic susceptibility to cefoxitin, norfloxacin, chloramphenicol and minocycline of the parental strain CR2000 (E. coli BW25113 ΔmarRA [2]) and of its 24 gene-inactivated mutant derivatives was determined by Etest as described previously [2]. Briefly, the different strains were grown overnight in Luria–Bertani (LB) medium (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl) at 37 °C with agitation and their minimum inhibitory concentrations were determined using Mueller–Hinton plates and Etest strips (AB BIODISK, Solna, Sweden) according to the manufacturer’s specifications following incubation for 20 h at 37 °C. The results for each mutant were compared with those of the parental strain by t-test (two independent samples with equal variance, two-tailed distribution, performed using Microsoft® Excel 2003 software) to determine statistically significant differences.

Nine (60%) of the fifteen genes functionally related to MarA-mediated antibiotic resistance also affected antibiotic susceptibility/resistance independently from MarA. Such a double role might help cells to have a more co-ordinated response to antibiotics. In contrast, only two (22%) of the nine genes that do not affect MarA-mediated antibiotic resistance affected antibiotic susceptibility/resistance (Table 1).

Table 1
Effect of inactivation of chromosomal genes functionally related or unrelated to MarA-mediated antibiotic resistance on antibiotic susceptibility in Escherichia coli

Those genes that affect both antibiotic resistance mediated by MarA and antibiotic susceptibility/resistance independently from MarA were as follows. First, acrA, acrB and tolC, whose inactivation strongly increased susceptibility to all the antibiotics tested (Table 1), as expected [1]. Second, crp, cyaA, hns and degP, whose inactivation increased resistance to cefoxitin (crp and hns) or norfloxacin (crp and cyaA), increased susceptibility to cefoxitin (degP) and strongly increased susceptibility to chloramphenicol and minocycline (hns) (Table 1). Inactivation of crp and cyaA was previously shown to produce resistance to some β-lactams [3] and fosfomycin [4]. Inactivation of hns or degP was found to increase susceptibility to rifampicin, sulphonamide and vancomycin (hns), or rifampicin and sulfamethoxazole (degP) in the Keio collection screen [1]. And finally, pcnB and nikD, two genes with no previous known role in antibiotic resistance whose inactivation increased resistance to cefoxitin (pcnB) or minocycline (nikD) (Table 1).

Only two genes that did not affect MarA-mediated antibiotic resistance (ompR and metL) affected antibiotic susceptibility/resistance (Table 1). Inactivation of ompR affected resistance to cefoxitin (in agreement with previous studies [3,5]) and norfloxacin. Inactivation of metL, a gene with no previous known role in antibiotic susceptibility, produced a small but statistically significant increase in susceptibility to cefoxitin (Table 1).

We have found that genes known to affect MarA-mediated antibiotic resistance were three times more likely to affect antibiotic susceptibility per se than genes that do not affect MarA-mediated antibiotic resistance. Moreover, these experiments have allowed us to confirm and expand the role of crp, cyaA, hns, degP and ompR in antibiotic susceptibility in E. coli and to identify three new genes (pcnB, nikD and metL) previously not known to affect antibiotic susceptibility in any bacterium. These findings support our proposed approach of studying genes that have functional interactions with other genes associated with drug resistance as a method to identify genes that independently affect antibiotic susceptibility.

Acknowledgments

Funding

This work was supported by a United States Public Health Service grant (AI56021) from the National Institutes of Health to SBL.

Footnotes

Competing interests

None declared.

Ethical approval

Not required.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

1. Tamae C, Liu A, Kim K, Sitz D, Hong J, Becket E, et al. Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli. J Bacteriol. 2008;190:5981–8. [PMC free article] [PubMed]
2. Ruiz C, Levy SB. Many chromosomal genes modulate MarA-mediated multidrug resistance in Escherichia coli. Antimicrob Agents Chemother. 2010;54:2125–34. [PMC free article] [PubMed]
3. Jaffé A, Chabbert YA, Derlot E. Selection and characterization of β-lactam-resistant Escherichia coli K-12 mutants. Antimicrob Agents Chemother. 1983;23:622–5. [PMC free article] [PubMed]
4. Sakamoto Y, Furukawa S, Ogihara H, Yamasaki M. Fosmidomycin resistance in adenylate cyclase deficient (cya) mutants of Escherichia coli. Biosci Biotechnol Biochem. 2003;67:2030–3. [PubMed]
5. Hirakawa H, Nishino K, Yamada J, Hirata T, Yamaguchi A. β-Lactam resistance modulated by the overexpression of response regulators of two-component signal transduction systems in Escherichia coli. J Antimicrob Chemother. 2003;52:576–82. [PubMed]